Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials

By sjmartinez • August 31, 2023

Moser CB, Chew KW, Giganti MJ, Li JZ, Aga E, Ritz J, Greninger AL, Javan AC, Bender Ignacio R, Daar ES, Wohl DA, Currier JS, Eron JJ, Smith DM, Hughes MD; ACTIV-2/A5401 Study Team. Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials. J Infect Dis. 2023 Aug 31;228(Supplement_2):S101-S110. doi: 10.1093/infdis/jiad285. PMID: 37650235; PMCID: PMC10469328.

Tags: covid-19, Harbor UCLA, Infectious Diseases, linear regression for censored data, Publications, randomized trial, SARS-CoV-2 RNA

Characterising the protective vasodilatory effects of hypobaric hypoxia on the neurovascular coupling response

Leacy JK, Burns DP, Jendzjowsky NG, Braun C, Herrington BA, Wilson RJ, Vermeulen TD, Foster GE, Rosenberg AJ, Anderson GK, Rickards CA, Lucking EF, O'Halloran[...]

A difficult path to point-of-care measurement of glomerular filtration rate

Delanaye P, Glassock RJ. A difficult path to point-of-care measurement of glomerular filtration rate. Nat Rev Nephrol. 2025 Mar 12. doi: 10.1038/s41581-025-00947-0. Epub ahead of[...]

A humanized antibody against mucormycosis targets angioinvasion and augments the host immune response

Gu Y, Singh S, Alqarihi A, Alkhazraji S, Gebremariam T, Youssef EG, Liu H, Fan X, Jiang WR, Andes D, Cochrane TR, Schwartz JA, Filler[...]